Philosophy of Care
Dr. Mayadev believes in providing each patient with the most comprehensive cancer care in a supportive and compassionate environment. Her multidisciplinary approach to treatment focuses on the patient in a team oriented setting.
4501 X St., G-140
Sacramento, CA 95817
B.A., Case Western Reserve University, Cleveland, Ohio, 2000
University of Washington Medical School, Seattle, Washington, 2009
Medical Board of California, 2009
American Brachytherapy Society
American Society of Therapeutic Radiology and Oncology
Children's Oncology Group
Gynecologic Oncology Group
Physicians for Human Rights
Radiological Society of North America
Select Honors and Awards:
Selected UCD faculty delegate atendee to AAMC Early Women's Career Development Seminar, 2011
University of California, Davis, School of Medicine Mentor, Medical Student Research Fellowship Award, 2011
University of California, Davis, School of Medicine Mentor, Medical Student Research Fellowship Award, 2010
Merit award for poster presentation at ASCO meeting October 2010, 2010
Providence Portland Medical Center, International Aid Grant, Mental Health Workers to Counsel Women of Domestic and Sexual Abuse in Rural El Salvador, 2005
Select Recent Publications:
Mayadev J, Qi L, Lentz S, Benedict S, Courquin J, Dieterich S, Mathai M, Stern R, Valicenti R. Implant time and process efficiency for CT-guided high-dose-rate brachytherapy for cervical cancer. Brachytherapy. 2014 Feb 19. pii: S1538-4721(14)00024-5. doi: 10.1016/j.brachy.2014.01.004. [Epub ahead of print]
Mayadev J, Daly M, Chen A, Bold R, Chew H. The potential role of radiation therapy to the primary site of disease in stage IV breast cancer presenting with synchronous metastasis. Clin Breast Cancer. 2014 Feb;14(1):10-2. doi: 10.1016/j.clbc.2013.08.010. Epub 2013 Oct 30.
Rash DL, Lee YC, Kashefi A, Durbin-Johnson B, Mathai M, Valicenti R, Mayadev JS. Clinical response of pelvic and para-aortic lymphadenopathy to a radiation boost in the definitive management of locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2013 Oct 1;87(2):317-22. doi: 10.1016/j.ijrobp.2013.06.2031. Epub 2013 Jul 29.
Lee YC, Rash DL, Stern RL, Mayadev JS. The equivalent dose contribution from high-dose-rate brachytherapy to positive pelvic lymph nodes in locally advanced cervical cancer. Brachytherapy. 2013 Nov-Dec;12(6):555-9. doi: 10.1016/j.brachy.2013.06.002. Epub 2013 Jul 20.
Lim J, Durbin-Johnson B, Valicenti R, Mathai M, Stern RL, Mayadev J; Department of Radiation Oncology, University of California-Davis Cancer Center, Sacramento, CA. The impact of maximum rectal distention and tandem angle on rectal dose delivered in 3D planned gynecologic high dose-rate brachytherapy. Int J Gynecol Cancer. 2013 Jul;23(6):1078-83. doi: 10.1097/IGC.0b013e3182959030.
Mayadev JS, Douglas JG, Storer BE, Appelbaum FR, Storb R. Impact of Cranial Irradiation Added to Intrathecal Conditioning in Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia with Central Nervous System Involvement. Int J Radiat Oncol Biol Phys, *Epub ahead of print.
P Grimm, IBilliet, D Bostwick, D Crawford, A Dicker, S Frank, J Immerzeel, M Keyes, P Kupelian, R Lee, S Machtens, J Mayadev, B Moran, G Merrick, J Millar, M Roach, R Stock, K Shinohara, M Scholz, E Weber, A Zietman, M Zelefsky, J Wong, S Wentworth, R Vera, S Langley. Comparative analysis of PSA free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. BJUInt, 2011:109(1S); 22-29.
Stanic S, Mathai M, Mayadev JS, Do LV, Purdy JA, Chen AM. Addition of a third field significantly increases dose to the brachial plexus for patients undergoing tangential whole-breast therapy after lumpectomy Med Dosim. 2011 Sep 24. [Epub ahead of print]
Mayadev J, Merrick GS, Reed JR, Butler WM, Galbreath RW, Allen ZA, Wallner KE. Permanent prostate brachytherapy in prostate glands <20 cm(3). Int J Radiat Oncol Biol Phys, 76(5): 1450-5. 2010
Gokhale AS, Mayadev J, Pohlman B, Macklis RM. Gamma camera scans and pretreatment tumor volumes as predictors of response and progression after Y-90 anti-CD20 radioimmunotherapy. Int J Radiat Oncol Biol Phys, 63(1): 194-201. 2005